吉林轻度前列腺炎治疗方法吉林看阳痿大概需要多少价钱,吉林治疗包皮大约要花多少钱,吉林包皮系带撕裂手术多少钱,吉林去哪个做包皮手术的医院,吉林男性前列腺炎的治疗医院,吉林治包皮过长价格,吉林男性包皮手术价格

The University of Missouri-Kansas City has filed a lawsuit against a former professor, alleging that he stole and sold his graduate student's research for .5 million.The suit, filed this week, says Ashim Mitra swiped a "groundbreaking" drug formulation from the student and stands to gain as much as million more in royalties.Mitra, who has resigned from the university, denied the allegations to CNN.Also named in the lawsuit are Mitra's wife, who worked in her husband's lab, and two pharmaceutical companies that used the invention.The university alleges Mitra worked in secret with the companies to develop the patent, which outlines an innovative way of delivering drugs to the eye using nanotechnologyThe pharmaceutical product has recently received FDA approval, the university said. It's a treatment for dry eye, an ailment common to the elderly.The university's contentionIn a statement to CNN, the university said:"Mitra stole UMKC-owned inventions, sold them to industry, assisted those companies in patenting and commercializing them, denied credit to a deserving student and reaped a personal financial windfall -- all the while concealing his efforts and denying his involvement."The lawsuit seeks to designate the student, Kishore Cholkar, as the rightful inventor to the patent based on his research from 2010.The university policy is that it owns the rights to discoveries made by staff and students while they are working at the university. When commercial rewards are reaped, the inventor is entitled to one-third of the profits and the school keeps the remaining two-thirds, the school said.The professor's reactionReached by phone Thursday, the professor denied the allegations and told CNN that Cholkar doesn't deserve credit for the patent."Everyone is trying to jump in and get a piece of the pie," he said.He said he conceived of the formulation with the drug companies through his private consultancy business, adding that "the student arrived after the patent was signed."Cholkar's work involved a part of the eye not affected by the drug, Mitra said.He added that he's consulting with his lawyers on how best to tackle the lawsuit.Cholkar, the student, now works at a California-based pharmaceutical company. CNN has reached out to Cholkar for comment. 2298

The Senate passed a bill Tuesday to fund the 9/11 Victim Compensation Fund for decades, permanently compensating individuals who were injured during the 2001 terrorist attacks and their aftermath rescuing people and removing debris under hazardous conditions.The vote was 97-2 and supporters cheered when the vote was nearly over.The House passed the bill earlier this month and President Donald Trump is expected to sign it.Comedian Jon Stewart and surviving first responders including John Feal pushed Congress to pass the extension before rewards diminished and the fund expired in 2020."For tens of thousands of people that are waiting to hear the outcome of this, my heart bleeds with joy, knowing that so many people are going to get help," Feal told CNN. "Everything we asked for, we got."Feal said he gave 15 years of his life to the cause and the passage of the bill would change him. "I get to physically and mentally heal," Feal said.In the face of dwindling resources and a surge in claims, the fund's administrator announced in February that it would need to significantly reduce its awards. Special Master Rupa Bhattacharyya said the fund received over 19,000 compensation forms from 2011 to 2016 and almost 20,000 more from 2016 to 2018 in part due to an increased rate of serious illnesses.The original fund from 2001 to 2004 distributed over billion to compensate the families of over 2,880 people who died on 9/11 and 2,680 individuals who were injured, according to the Justice Department. In 2011, Congress reactivated the fund and in 2015 reauthorized it for another five years, appropriating .4 billion to aid thousands more people. The fund was set to stop taking new claims in December 2020.The new bill would extend the expiration date for decades and cost what is deemed necessary. The Congressional Budget Office estimates it will cost about billion over the next decade. Last week, Sen. Rand Paul, R-Kentucky, delayed the bill's passage, criticizing Congress for not offsetting its cost by not cutting government spending elsewhere.The bill is named after James Zadroga, Luis Alvarez and Ray Pfeifer, two New York police detectives and a firefighter who responded to the September 11, 2001, terrorist attacks and died due to health complications attributed to their work at Ground Zero. 2335

This article contains spoilers for the series finale of "Game of Thrones." Some say the world will end in fire. / Some say in ice.And so, 151

Three women working at an assisted living and memory care facility in North Carolina were arrested Friday after allegedly running a fight club where they encouraged elderly patients with dementia to fight each other, police said. Police received a report of abuse at the Danby House in Winston-Salem, North Carolina, back in June, 343

Trying to make a complaint against your student loan lender or servicer may feel like screaming into the void.In 2019, federal student aid customers made 44,155 complaints using the Federal Student Aid Feedback System, according to the most recent report of the Federal Student Aid Ombudsman. The most common complaints dealt with repaying loans.The Department of Education, in an email, said while all complaints will be reviewed and responded to, “we cannot guarantee a customer a specific result or change in their current situation.”Don’t let that stop you from voicing your concerns to the powers that be.Before you send off a fiery email, set reasonable expectations about the outcome — it may not be what you want. But it’s possible to get a result if you know the right steps to take.Start with your lender or servicerYou’ll see results fastest by contacting your private lender or 902